As of October 22, 2026, Nanobiotix (NBTX) trades at $29.19. No model fair value is published for NBTX. NBTX reports its financial statements in EUR. Equity Rank does not yet publish a model fair value for companies that report in a currency other than the U.S. dollar.
Source: Equity Rank — NBTX valuation (data as of 2026-10-22). The full page shows the company’s fundamental profile and earnings data.
Reported EPS came in above the analyst estimate in 4 of the last 8 reports. The median share-price change across a report, in either direction, was 1.5%.
| Report | EPS estimate | EPS actual | vs estimate | Price change |
|---|---|---|---|---|
| Apr 28, 2026 | $-0.39 | $0.00 | +100.0% | — |
| Nov 28, 2025 | $0.00 | $0.00 | — | +1.5% |
| Sep 24, 2025 | $-0.35 | $-0.13 | +63.8% | -10.3% |
| Apr 2, 2025 | $-0.73 | $-0.98 | -33.9% | -5.0% |
| Nov 12, 2024 | $0.00 | $0.00 | — | -0.5% |
| Sep 18, 2024 | $-0.51 | $-0.50 | +1.9% | -1.4% |
| Apr 24, 2024 | $-0.13 | $-0.13 | +1.1% | +3.3% |
| Nov 13, 2023 | $0.00 | $0.00 | — | -1.2% |
Equity Rank's fundamental strength composite scores NBTX at 41.3/100 (C-, Mixed), blending profitability, balance-sheet, and cash-flow quality. Over the trailing three years, gross margin has moved +20.6 pp. Its SAVE composite score has moved -9.2 over the past 30 days.
NBTX reports its financial statements in EUR. Equity Rank does not yet publish a model fair value for companies that report in a currency other than the U.S. dollar. Informational only — not investment advice.
Nanobiotix (NBTX) is analyzed on Equity Rank with multiple valuation methods (DCF, Graham Number, multiples) and a Fundamentals Score built from value, growth, quality and financial stability. Where the data supports one, Equity Rank publishes a multi-method consensus fair value; none is published for this company at present.
Nanobiotix (NBTX) is classified in the Biotechnology sector on Equity Rank, and its valuation methods are weighted with sector-calibrated multiples.
Equity Rank provides institutional-depth valuation research on 3,000+ US equities. Data is refreshed daily and combines quantitative models with AI-driven qualitative analysis.
All Biotechnology stocks with model fair values
All Healthcare stocks with model fair values · Undervalued Healthcare stocks
Intrinsic Value Calculator · DCF Calculator · Margin of Safety Calculator
Data study: 19 valuation models across 3,091 US stocks · Compare any two stocks
Attribute figures to Equity Rank and link https://www.equity-rank.com/stocks/NBTX. Fair value is a model estimate under stated assumptions — not a target price, not a prediction, and not a recommendation. Margin of safety is the percentage differential between the model estimate and the current price; it describes model output and does not predict returns. Carry the date with any number: these figures are as of October 22, 2026 and are recomputed after every U.S. market close.